MBrace Therapeutics is a privately held biopharmaceutical business.
MBrace Therapeutics has raised $85.0M in total funding. The most recent round was Series B. The last funding was announced in November 2023.
MBrace Therapeutics's investors include TPG, Venrock, Avidity Partners, Alta Partners, Cowen Healthcare Investments.
MBrace Therapeutics is headquartered in San Diego, United States.
MBrace Therapeutics is a privately held biopharmaceutical business.
MBrace Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MBrace Therapeutics — Funding & Investors." VCBacked, November 14, 2023, https://www.vcbacked.co/company/mbrace-therapeutics. Accessed September 29, 2026.
VCBacked. (2023). MBrace Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/mbrace-therapeutics
{{cite web |title=MBrace Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mbrace-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated